Physician Assistant in Nashua, NH Accepting Medicare
108 Physician Assistant nurses found. Showing 101 - 108
 Scott Savner, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-882-8375 Fax: 603-886-7163 |
Mr. Denis Robert, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4000 |
 Ms. Melissa Ann Marshall, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 22 Prospect St, Nashua, NH 03060 Phone: 497-731-2194 Fax: 978-824-3872 |
Sarah M Farris, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 460 Amherst St, Nashua, NH 03063 Phone: 603-883-7970 Fax: 603-595-3652 |
Mrs. Marissa Berry, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 21 E Hollis St, Nashua, NH 03060 Phone: 603-577-2273 |
Jennifer E Ferreira, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-477-5000 |
Amjed John, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St, Nashua, NH 03060 Phone: 603-577-2663 Fax: 603-577-3366 |
Ms. Mary Peterson, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 460 Amherst St, Nashua, NH 03063 Phone: 603-883-7970 Fax: 603-595-3652 |
News Archive
US Court of Appeals confirms District Court decision in Watson's Sanctura XR patent suit
Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the District of Delaware's March 31, 2012 decision that the asserted claims of U.S. Patent Nos. 7,410,978; 7,759,359; 7,781,448; 7,781,449 and 7,763,635 relating to Sanctura XR (trospium chloride extended-release capsules) are invalid.
Stereotactic radiosurgery could be more effective for patients with few metastatic brain tumors
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
Researchers explore genetic and cellular mechanisms of retinal development
The circuitry of the central nervous system is immensely complex and, as a result, sometimes confounding. When scientists conduct research to unravel the inner workings at a cellular level, they are sometimes surprised by what they find.
TRACON to present data on TRC105, TRC102 cancer therapies at EORTC-NCI-AACR Symposium
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that new data on TRC105 and TRC102 will be presented at the 22nd Annual EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
› Verified 8 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR